Showing 1731-1740 of 2192 results for "".
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31390/New AAN Guidelines Enhance Carotid Artery Stenosis ManagementThe American Academy of Neurology (AAN) recently published updated guidelines in *Neurology* (2005;65:794-80) addressing the surgical management of carotid artery stenosis. Synthesizing data from multiple trials between 1990 and 2001, the
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31400/Recent advancements in Alzheimer’s disease (AD) research are shedding light on its elusive etiology and pathophysiology, offering new insights for healthcare professionals. A significant study published in the *American Journal of Industrial Medicine* analyzed 2.6 million death records from 22 state
- Vascular Clinichttps://practicalneurology.com/columns/practice-management/vascular-clinic/31404/Enhancing TIA Management with the ABCD Scoring SystemTransient ischemic attacks (TIAs) present a critical challenge in neurology due to their transient nature and the imperative decision of inpatient versus outpatient management. Historically, the lack of standardized clinical guidelines has resulte
- Vascular Clinichttps://practicalneurology.com/columns/practice-management/vascular-clinic/31434/The resurgence of the antiplatelet resistance debate has rekindled discussions within the stroke care community, particularly concerning the optimal aspirin dosage for stroke prophylaxis. Historically, low-dose aspirin (≤325 mg) has been deemed as effective as higher doses in preventing both cardiov
- Editor's Messagehttps://practicalneurology.com/columns/practice-management/editors-message/31450/In the May 2005 issue of *Practical Neurology*, Editor Jack Persico addresses the contentious topic of integrating profitable clinical procedures into neurology practices. This discussion was sparked by a previous article titled “Bringing in the Bucks with Botox,” which faced criticism from readers
- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0505Dementia-pdf/31449/Mild Cognitive Impairment (MCI) remains a contentious topic in neurology, particularly regarding its role in predicting Alzheimer’s disease (AD). Dr. David S. Geldmacher highlights the complexities and uncertainties surrounding the clinical implementation of MCI. While everyday forgetfulness might b
- Epilepsy Essentials: Exploring the Mysterious Link Between Sleep and Epilepsyhttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN0305Epilepsy-pdf/31479/Sleep plays a crucial role in overall health, occupying about one-third of our lives. In the medical field, particularly among physicians and nurses, sleep deprivation is recognized for its detrimental effects on cognitive functions such as memory, attention, and concentration, which can lead to inc
- Therapeutics Q&Ahttps://practicalneurology.com/columns/practice-management/therapeutics-qa/31184/Integrating Antidepressant Therapy in Parkinson’s Disease ManagementDepression is a common comorbidity in Parkinson’s disease (PD) patients, necessitating careful consideration for antidepressant therapy. Dr. Eric J. Ahlskog, a leading neurologist at the Mayo Clinic, emphasizes the interplay between
- Will Generics Gobble Up The Neurology Market?https://practicalneurology.com/columns/practice-management/will-generics-gobble-up-the-neurology-market/31082/Generics Gain Ground in Neurology: Implications for Clinical PracticeThe landscape of neurology pharmacotherapy is shifting as generic medications increasingly replace brand-name drugs, promising substantial cost savings without compromising efficacy. As highlighted in the December 2007 issue of *Pr
- Movement Disorders Focushttps://practicalneurology.com/diseases-diagnoses/movement-disorders/pn0407-movemntdis-pdf/31190/Tardive Dyskinesia: Overview, Causes, and ManagementTardive dyskinesia (TD) represents a complex group of involuntary, repetitive movements primarily resulting from prolonged use of dopamine-receptor antagonists (DRAs), including both typical and atypical antipsychotic medications. TD is characteriz